AZD9150, A NEXT-GENERATION ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF STAT3 WITH EARLY EVIDENCE OF CLINICAL ACTIVITY IN LYMPHOMA AND LUNG CANCER

Sunday, July 26, 2015